Estradiol; Norgestimate is used for managing menopausal symptoms and preventing osteoporosis in women with a uterus. It was first introduced by Teva Womens Health Inc in its drug Prefest on Oct 22, 1999. 2 different companies have introduced drugs containing Estradiol; Norgestimate.

Estradiol; Norgestimate Patents

Given below is the list of patents protecting Estradiol; Norgestimate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Prefest	US7320970	Low dose estrogen interrupted hormone replacement therapy	Mar 30, 2020 (Expired)	Teva Womens
Prefest	US6747019	Low dose estrogen interrupted hormone replacement therapy	Mar 20, 2020 (Expired)	Teva Womens

Add above patents to watchlist

Estradiol; Norgestimate's Family Patents

Unlock Global Patents

Estradiol; Norgestimate Generic API Manufacturers

Only one generic application has been filed for Estradiol; Norgestimate.

Given below is the list of companies who have filed for Estradiol; Norgestimate generic, along with the locations of their manufacturing plants worldwide.